Literature DB >> 15757239

Principal component for metabolic syndrome risk maps to chromosome 4p in Mexican Americans: the San Antonio Family Heart Study.

Guowen Cai1, Shelley A Cole, Jeanne H Freeland-Graves, Jean W MacCluer, John Blangero, Anthony G Comuzzie.   

Abstract

Metabolic syndrome refers to the clustering of disease conditions such as insulin resistance, hyperinsulinemia, dyslipidemia, hypertension, and obesity. To explore the genetic predispositions of this complex syndrome, we conducted a principal components analysis using data on 14 phenotypes related to the risk of developing metabolic syndrome. The subjects were 566 nondiabetic Mexican Americans, distributed in 41 extended families from the San Antonio Family Heart Study. The factor scores obtained from these 14 phenotypes were used in multipoint linkage analysis using SOLAR. Factors were identified that accounted for 73% of the total variance of the original variables: body size-adiposity, insulin-glucose, blood pressure, and lipid levels. Each factor exhibited evidence for either significant or suggestive linkage involving four factor-specific chromosomal regions relating to chromosomes 1, 3, 4, and 6. Significant evidence for linkage of the lipid factor was found on chromosome 4 near marker D4S403 (LOD = 3.52), where the cholecystokinin A receptor (CCKAR) and ADP-ribosyl cyclase 1 (CD38) genes are located. Suggestive evidence for linkage of the body size-adiposity factor to chromosome 1 near marker D1S1597 (LOD = 2.53) in the region containing the nuclear receptor subfamily 0, group B, member 2 gene (NROB2) also was observed. The insulin-glucose and blood pressure factors were linked suggestively to regions on chromosome 3 near marker D3S1595 (LOD = 2.20) and on chromosome 6 near marker D6S 1031 (LOD = 2.08), respectively. In summary, our findings suggest that the factor structures for the risk of metabolic syndrome are influenced by multiple distinct genes across the genome.

Entities:  

Mesh:

Year:  2004        PMID: 15757239     DOI: 10.1353/hub.2005.0001

Source DB:  PubMed          Journal:  Hum Biol        ISSN: 0018-7143            Impact factor:   0.553


  10 in total

1.  Systems genetics of the nuclear factor-κB signal transduction network. I. Detection of several quantitative trait loci potentially relevant to aging.

Authors:  Vincent P Diego; Joanne E Curran; Jac Charlesworth; Juan M Peralta; V Saroja Voruganti; Shelley A Cole; Thomas D Dyer; Matthew P Johnson; Eric K Moses; Harald H H Göring; Jeff T Williams; Anthony G Comuzzie; Laura Almasy; John Blangero; Sarah Williams-Blangero
Journal:  Mech Ageing Dev       Date:  2011-12-01       Impact factor: 5.432

2.  Metabolic syndrome in a metapopulation of Croatian island isolates.

Authors:  Ivana Kolcić; Ariana Vorko-Jović; Branka Salzer; Mladen Smoljanović; Josipa Kern; Silvije Vuletić
Journal:  Croat Med J       Date:  2006-08       Impact factor: 1.351

Review 3.  Genetic determinants of the metabolic syndrome.

Authors:  Michèle M Sale; Jonathan Woods; Barry I Freedman
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

4.  A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans.

Authors:  Sobha Puppala; Gerald D Dodd; Sharon Fowler; Rector Arya; Jennifer Schneider; Vidya S Farook; Richard Granato; Thomas D Dyer; Laura Almasy; Christopher P Jenkinson; Andrew K Diehl; Michael P Stern; John Blangero; Ravindranath Duggirala
Journal:  Am J Hum Genet       Date:  2006-01-06       Impact factor: 11.025

Review 5.  The CD38 glycohydrolase and the NAD sink: implications for pathological conditions.

Authors:  Julianna D Zeidler; Kelly A Hogan; Guillermo Agorrody; Thais R Peclat; Sonu Kashyap; Karina S Kanamori; Lilian Sales Gomez; Delaram Z Mazdeh; Gina M Warner; Katie L Thompson; Claudia C S Chini; Eduardo Nunes Chini
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-09       Impact factor: 4.249

Review 6.  CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.

Authors:  Eduardo Nunes Chini
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

7.  A German genome-wide linkage scan for type 2 diabetes supports the existence of a metabolic syndrome locus on chromosome 1p36.13 and a type 2 diabetes locus on chromosome 16p12.2.

Authors:  K Hoffmann; M Mattheisen; S Dahm; P Nürnberg; C Roe; J Johnson; N J Cox; H E Wichmann; T F Wienker; J Schulze; P E Schwarz; T H Lindner
Journal:  Diabetologia       Date:  2007-04-27       Impact factor: 10.122

8.  Principal component and linkage analysis of cardiovascular risk traits in the Norfolk isolate.

Authors:  Hannah C Cox; Claire Bellis; Rod A Lea; Sharon Quinlan; Roger Hughes; Thomas Dyer; Jac Charlesworth; John Blangero; Lyn R Griffiths
Journal:  Hum Hered       Date:  2009-04-01       Impact factor: 0.444

9.  Role of Thioredoxin 1 in Impaired Renal Sodium Excretion of hD 5 R F173L Transgenic Mice.

Authors:  Shaoxiong Wang; Xiaorong Tan; Peng Chen; Shuo Zheng; Hongmei Ren; Jin Cai; Lin Zhou; Pedro A Jose; Jian Yang; Chunyu Zeng
Journal:  J Am Heart Assoc       Date:  2019-04-16       Impact factor: 5.501

10.  Genome-wide association analysis of metabolic syndrome quantitative traits in the GENNID multiethnic family study.

Authors:  Jia Y Wan; Deborah L Goodman; Emileigh L Willems; Alexis R Freedland; Trina M Norden-Krichmar; Stephanie A Santorico; Karen L Edwards
Journal:  Diabetol Metab Syndr       Date:  2021-06-01       Impact factor: 3.320

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.